StockData
Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd (TEVA) stock

TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30135% above fair value
$42.62+0.05 (+0.12%)

Close on Nov 17, 2026Market cap $49.66BP/E 71.0Yield –

Teva Pharmaceutical Industries price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Teva Pharmaceutical Industries's price to book ratio was 6.4× on Nov 10, 2026, against 4.3× a year earlier. Over the last 5 years it ranged from 0.8× to 6.4×, with a median of 2.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 20266.4×+1.4
2025Dec 31, 20255.0×+0.9
2024Dec 31, 20244.1×+2.4
2023Dec 29, 20231.7×+0.5
2022Dec 30, 20221.2×+0.3
2021Dec 31, 20210.8×−0.3
2020Dec 31, 20201.1×+0.3
2019Dec 31, 20190.8×−0.1
2018Dec 31, 20180.9×+0.0
2017Jan 31, 20170.9×−0.1
2016Dec 30, 20161.0×−1.5
2015Dec 31, 20152.5×+0.4
2014Dec 31, 20142.1×+0.5
2013Dec 31, 20131.5×+0.1
2012Dec 31, 20121.4×−0.2
2011Dec 30, 20111.6×−0.7
2010Dec 31, 20102.3×−0.4
2009Dec 31, 20092.7×–

More Teva Pharmaceutical Industries figures

See a number that looks wrong?